Bioaccumulation of therapeutic drugs by human gut bacteria

Martina Klünemann(Evonik (Germany)), Kiran Raosaheb Patil(European Molecular Biology Laboratory), Mikhail M. Savitski(European Molecular Biology Organization), Saravanan Devendran(University of Illinois Urbana-Champaign), Eleni Kafkia(University of Cambridge), Prasad Phapale(European Molecular Biology Laboratory), Eleonora Mastrorilli(European Molecular Biology Laboratory), Vinita Periwal(European Molecular Biology Laboratory), Daniel C. Sévin(GlaxoSmithKline (Germany)), Michael Zimmermann(ETH Zurich), Thomas Bock(European Molecular Biology Laboratory), Bernd Simon(European Molecular Biology Laboratory), Manjeet Kumar(European Molecular Biology Laboratory), Martin Beck(European Molecular Biology Laboratory), Filipe Cabreiro(Institute of Structural and Molecular Biology), Timothy A. Scott(Institute of Structural and Molecular Biology), Ana Rita Brochado(Technical University of Denmark), Athanasios Typas(European Molecular Biology Laboratory), André Mateus(Umeå University), Janosch Hennig(European Molecular Biology Laboratory), Leo Nesme(European Molecular Biology Laboratory), Manuel Banzhaf(European Molecular Biology Laboratory), Katharina Zirngibl(European Molecular Biology Laboratory), Carsten Schultz(European Molecular Biology Laboratory), Lisa Maier(University of Tübingen), Peer Bork(Max Delbrück Center), Sonja Blasche(European Molecular Biology Laboratory), Felix Hövelmann(European Molecular Biology Laboratory), Melanie Tramontano(German Cancer Research Center), Johanna Vappiani(GlaxoSmithKline (Germany)), Yongkyu Kim(European Molecular Biology Laboratory), Marie‐Therese Mackmull(ETH Zurich), Dimitrios Konstantinidis(European Molecular Biology Laboratory), Sergej Andrejev(German Cancer Research Center)
Nature
September 8, 2021
Cited by 313


Related Papers